Financhill
Buy
54

DCTH Quote, Financials, Valuation and Earnings

Last price:
$9.89
Seasonality move :
-5.79%
Day range:
$10.02 - $10.22
52-week range:
$8.12 - $18.23
Dividend yield:
0%
P/E ratio:
1,160.92x
P/S ratio:
4.82x
P/B ratio:
3.11x
Volume:
300.5K
Avg. volume:
628.7K
1-year change:
-16.11%
Market cap:
$356.7M
Revenue:
$37.2M
EPS (TTM):
$0.01

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
DCTH
Delcath Systems, Inc.
$20M -$0.03 32.37% -69.37% $22.31
CTSO
CytoSorbents Corp.
$9.9M -$0.07 51.05% -41.38% $4.92
EXAS
EXACT Sciences Corp.
$860.7M $0.08 20.65% -84.17% $104.56
ILMN
Illumina, Inc.
$1.1B $1.23 -0.1% 4.82% $125.28
NTRA
Natera, Inc.
$576.7M -$0.58 21.14% -42.93% $246.26
STRR
Star Operating Cos., Inc.
$16.8M -$0.76 50.04% -65.48% $12.00
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
DCTH
Delcath Systems, Inc.
$10.10 $22.31 $356.7M 1,160.92x $0.00 0% 4.82x
CTSO
CytoSorbents Corp.
$0.64 $4.92 $40.1M -- $0.00 0% 1.14x
EXAS
EXACT Sciences Corp.
$101.56 $104.56 $19.2B -- $0.00 0% 6.18x
ILMN
Illumina, Inc.
$131.16 $125.28 $20B 29.39x $0.00 0% 4.82x
NTRA
Natera, Inc.
$229.09 $246.26 $31.9B -- $0.00 0% 14.60x
STRR
Star Operating Cos., Inc.
$11.25 $12.00 $38.7M 0.75x $0.00 0% 0.54x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
DCTH
Delcath Systems, Inc.
0.83% 2.032 0.25% 12.82x
CTSO
CytoSorbents Corp.
75.25% 1.234 46.74% 1.49x
EXAS
EXACT Sciences Corp.
50.33% 1.440 24.46% 2.24x
ILMN
Illumina, Inc.
51.97% 2.443 17.73% 1.04x
NTRA
Natera, Inc.
13.7% 1.258 0.9% 3.03x
STRR
Star Operating Cos., Inc.
26.85% 8.200 70.75% 0.76x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
DCTH
Delcath Systems, Inc.
$17.9M -$388K 1.56% 1.59% -1.89% $4.3M
CTSO
CytoSorbents Corp.
$6.7M -$2.7M -27.15% -89.32% -28.07% -$2.5M
EXAS
EXACT Sciences Corp.
$583.9M $16.3M -18.87% -38% 1.91% $190M
ILMN
Illumina, Inc.
$732M $231M 14.3% 30.55% 21.33% $253M
NTRA
Natera, Inc.
$384.4M -$97.6M -21.88% -26.6% -16.48% $24.5M
STRR
Star Operating Cos., Inc.
$5.6M -$866K -2.74% -3.67% -3.65% -$2.4M

Delcath Systems, Inc. vs. Competitors

  • Which has Higher Returns DCTH or CTSO?

    CytoSorbents Corp. has a net margin of 4.04% compared to Delcath Systems, Inc.'s net margin of -33.42%. Delcath Systems, Inc.'s return on equity of 1.59% beat CytoSorbents Corp.'s return on equity of -89.32%.

    Company Gross Margin Earnings Per Share Invested Capital
    DCTH
    Delcath Systems, Inc.
    87.24% $0.02 $115.8M
    CTSO
    CytoSorbents Corp.
    70.28% -$0.05 $36.4M
  • What do Analysts Say About DCTH or CTSO?

    Delcath Systems, Inc. has a consensus price target of $22.31, signalling upside risk potential of 120.84%. On the other hand CytoSorbents Corp. has an analysts' consensus of $4.92 which suggests that it could grow by 669.19%. Given that CytoSorbents Corp. has higher upside potential than Delcath Systems, Inc., analysts believe CytoSorbents Corp. is more attractive than Delcath Systems, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    DCTH
    Delcath Systems, Inc.
    5 0 0
    CTSO
    CytoSorbents Corp.
    1 1 0
  • Is DCTH or CTSO More Risky?

    Delcath Systems, Inc. has a beta of 0.393, which suggesting that the stock is 60.664% less volatile than S&P 500. In comparison CytoSorbents Corp. has a beta of 1.320, suggesting its more volatile than the S&P 500 by 31.967%.

  • Which is a Better Dividend Stock DCTH or CTSO?

    Delcath Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CytoSorbents Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Delcath Systems, Inc. pays -- of its earnings as a dividend. CytoSorbents Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios DCTH or CTSO?

    Delcath Systems, Inc. quarterly revenues are $20.6M, which are larger than CytoSorbents Corp. quarterly revenues of $9.5M. Delcath Systems, Inc.'s net income of $830K is higher than CytoSorbents Corp.'s net income of -$3.2M. Notably, Delcath Systems, Inc.'s price-to-earnings ratio is 1,160.92x while CytoSorbents Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Delcath Systems, Inc. is 4.82x versus 1.14x for CytoSorbents Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DCTH
    Delcath Systems, Inc.
    4.82x 1,160.92x $20.6M $830K
    CTSO
    CytoSorbents Corp.
    1.14x -- $9.5M -$3.2M
  • Which has Higher Returns DCTH or EXAS?

    EXACT Sciences Corp. has a net margin of 4.04% compared to Delcath Systems, Inc.'s net margin of -2.3%. Delcath Systems, Inc.'s return on equity of 1.59% beat EXACT Sciences Corp.'s return on equity of -38%.

    Company Gross Margin Earnings Per Share Invested Capital
    DCTH
    Delcath Systems, Inc.
    87.24% $0.02 $115.8M
    EXAS
    EXACT Sciences Corp.
    68.64% -$0.10 $5B
  • What do Analysts Say About DCTH or EXAS?

    Delcath Systems, Inc. has a consensus price target of $22.31, signalling upside risk potential of 120.84%. On the other hand EXACT Sciences Corp. has an analysts' consensus of $104.56 which suggests that it could grow by 2.96%. Given that Delcath Systems, Inc. has higher upside potential than EXACT Sciences Corp., analysts believe Delcath Systems, Inc. is more attractive than EXACT Sciences Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    DCTH
    Delcath Systems, Inc.
    5 0 0
    EXAS
    EXACT Sciences Corp.
    3 18 0
  • Is DCTH or EXAS More Risky?

    Delcath Systems, Inc. has a beta of 0.393, which suggesting that the stock is 60.664% less volatile than S&P 500. In comparison EXACT Sciences Corp. has a beta of 1.404, suggesting its more volatile than the S&P 500 by 40.386%.

  • Which is a Better Dividend Stock DCTH or EXAS?

    Delcath Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. EXACT Sciences Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Delcath Systems, Inc. pays -- of its earnings as a dividend. EXACT Sciences Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios DCTH or EXAS?

    Delcath Systems, Inc. quarterly revenues are $20.6M, which are smaller than EXACT Sciences Corp. quarterly revenues of $850.7M. Delcath Systems, Inc.'s net income of $830K is higher than EXACT Sciences Corp.'s net income of -$19.6M. Notably, Delcath Systems, Inc.'s price-to-earnings ratio is 1,160.92x while EXACT Sciences Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Delcath Systems, Inc. is 4.82x versus 6.18x for EXACT Sciences Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DCTH
    Delcath Systems, Inc.
    4.82x 1,160.92x $20.6M $830K
    EXAS
    EXACT Sciences Corp.
    6.18x -- $850.7M -$19.6M
  • Which has Higher Returns DCTH or ILMN?

    Illumina, Inc. has a net margin of 4.04% compared to Delcath Systems, Inc.'s net margin of 13.85%. Delcath Systems, Inc.'s return on equity of 1.59% beat Illumina, Inc.'s return on equity of 30.55%.

    Company Gross Margin Earnings Per Share Invested Capital
    DCTH
    Delcath Systems, Inc.
    87.24% $0.02 $115.8M
    ILMN
    Illumina, Inc.
    67.59% $0.97 $5B
  • What do Analysts Say About DCTH or ILMN?

    Delcath Systems, Inc. has a consensus price target of $22.31, signalling upside risk potential of 120.84%. On the other hand Illumina, Inc. has an analysts' consensus of $125.28 which suggests that it could fall by -4.49%. Given that Delcath Systems, Inc. has higher upside potential than Illumina, Inc., analysts believe Delcath Systems, Inc. is more attractive than Illumina, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    DCTH
    Delcath Systems, Inc.
    5 0 0
    ILMN
    Illumina, Inc.
    7 8 1
  • Is DCTH or ILMN More Risky?

    Delcath Systems, Inc. has a beta of 0.393, which suggesting that the stock is 60.664% less volatile than S&P 500. In comparison Illumina, Inc. has a beta of 1.409, suggesting its more volatile than the S&P 500 by 40.855%.

  • Which is a Better Dividend Stock DCTH or ILMN?

    Delcath Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Illumina, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Delcath Systems, Inc. pays -- of its earnings as a dividend. Illumina, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios DCTH or ILMN?

    Delcath Systems, Inc. quarterly revenues are $20.6M, which are smaller than Illumina, Inc. quarterly revenues of $1.1B. Delcath Systems, Inc.'s net income of $830K is lower than Illumina, Inc.'s net income of $150M. Notably, Delcath Systems, Inc.'s price-to-earnings ratio is 1,160.92x while Illumina, Inc.'s PE ratio is 29.39x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Delcath Systems, Inc. is 4.82x versus 4.82x for Illumina, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DCTH
    Delcath Systems, Inc.
    4.82x 1,160.92x $20.6M $830K
    ILMN
    Illumina, Inc.
    4.82x 29.39x $1.1B $150M
  • Which has Higher Returns DCTH or NTRA?

    Natera, Inc. has a net margin of 4.04% compared to Delcath Systems, Inc.'s net margin of -14.78%. Delcath Systems, Inc.'s return on equity of 1.59% beat Natera, Inc.'s return on equity of -26.6%.

    Company Gross Margin Earnings Per Share Invested Capital
    DCTH
    Delcath Systems, Inc.
    87.24% $0.02 $115.8M
    NTRA
    Natera, Inc.
    64.91% -$0.64 $1.5B
  • What do Analysts Say About DCTH or NTRA?

    Delcath Systems, Inc. has a consensus price target of $22.31, signalling upside risk potential of 120.84%. On the other hand Natera, Inc. has an analysts' consensus of $246.26 which suggests that it could grow by 7.5%. Given that Delcath Systems, Inc. has higher upside potential than Natera, Inc., analysts believe Delcath Systems, Inc. is more attractive than Natera, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    DCTH
    Delcath Systems, Inc.
    5 0 0
    NTRA
    Natera, Inc.
    12 2 0
  • Is DCTH or NTRA More Risky?

    Delcath Systems, Inc. has a beta of 0.393, which suggesting that the stock is 60.664% less volatile than S&P 500. In comparison Natera, Inc. has a beta of 1.620, suggesting its more volatile than the S&P 500 by 61.981%.

  • Which is a Better Dividend Stock DCTH or NTRA?

    Delcath Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Natera, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Delcath Systems, Inc. pays -- of its earnings as a dividend. Natera, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios DCTH or NTRA?

    Delcath Systems, Inc. quarterly revenues are $20.6M, which are smaller than Natera, Inc. quarterly revenues of $592.2M. Delcath Systems, Inc.'s net income of $830K is higher than Natera, Inc.'s net income of -$87.5M. Notably, Delcath Systems, Inc.'s price-to-earnings ratio is 1,160.92x while Natera, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Delcath Systems, Inc. is 4.82x versus 14.60x for Natera, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DCTH
    Delcath Systems, Inc.
    4.82x 1,160.92x $20.6M $830K
    NTRA
    Natera, Inc.
    14.60x -- $592.2M -$87.5M
  • Which has Higher Returns DCTH or STRR?

    Star Operating Cos., Inc. has a net margin of 4.04% compared to Delcath Systems, Inc.'s net margin of 14.56%. Delcath Systems, Inc.'s return on equity of 1.59% beat Star Operating Cos., Inc.'s return on equity of -3.67%.

    Company Gross Margin Earnings Per Share Invested Capital
    DCTH
    Delcath Systems, Inc.
    87.24% $0.02 $115.8M
    STRR
    Star Operating Cos., Inc.
    23.43% $0.86 $85.6M
  • What do Analysts Say About DCTH or STRR?

    Delcath Systems, Inc. has a consensus price target of $22.31, signalling upside risk potential of 120.84%. On the other hand Star Operating Cos., Inc. has an analysts' consensus of $12.00 which suggests that it could grow by 6.67%. Given that Delcath Systems, Inc. has higher upside potential than Star Operating Cos., Inc., analysts believe Delcath Systems, Inc. is more attractive than Star Operating Cos., Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    DCTH
    Delcath Systems, Inc.
    5 0 0
    STRR
    Star Operating Cos., Inc.
    1 1 0
  • Is DCTH or STRR More Risky?

    Delcath Systems, Inc. has a beta of 0.393, which suggesting that the stock is 60.664% less volatile than S&P 500. In comparison Star Operating Cos., Inc. has a beta of 2.711, suggesting its more volatile than the S&P 500 by 171.052%.

  • Which is a Better Dividend Stock DCTH or STRR?

    Delcath Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Star Operating Cos., Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Delcath Systems, Inc. pays -- of its earnings as a dividend. Star Operating Cos., Inc. pays out 19.54% of its earnings as a dividend. Star Operating Cos., Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios DCTH or STRR?

    Delcath Systems, Inc. quarterly revenues are $20.6M, which are smaller than Star Operating Cos., Inc. quarterly revenues of $23.7M. Delcath Systems, Inc.'s net income of $830K is lower than Star Operating Cos., Inc.'s net income of $3.5M. Notably, Delcath Systems, Inc.'s price-to-earnings ratio is 1,160.92x while Star Operating Cos., Inc.'s PE ratio is 0.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Delcath Systems, Inc. is 4.82x versus 0.54x for Star Operating Cos., Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DCTH
    Delcath Systems, Inc.
    4.82x 1,160.92x $20.6M $830K
    STRR
    Star Operating Cos., Inc.
    0.54x 0.75x $23.7M $3.5M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
30
CORT alert for Jan 2

Corcept Therapeutics, Inc. [CORT] is up 5.4% over the past day.

Buy
75
AXSM alert for Jan 2

Axsome Therapeutics, Inc. [AXSM] is down 3.78% over the past day.

Sell
50
NUTX alert for Jan 2

Nutex Health, Inc. [NUTX] is down 8.96% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock